Cagrilintide is an investigational clinical program.
Each answer stays attached to the compound identity and destination records. This is a verification guide, not medical or legal advice, a seller recommendation, or proof of availability.
Cagrilintide is an investigational clinical program. No seller listing in Malaysia can inherit the sponsor’s clinical identity, trial evidence, or regulatory status. Check any exact product and supplier claim in the destination records below.
Resolve the exact identity of Cagrilintide through REDEFINE 1 Phase 3 study - NCT05567796 from ClinicalTrials.gov. Then search QUEST3+ Product Search from National Pharmaceutical Regulatory Agency for the destination product record and Product registration FAQ from National Pharmaceutical Regulatory Agency for the seller, establishment, or supply route in Malaysia. A match in one record does not replace the other two checks.
No. A page using the name Cagrilintide, local currency, a domestic delivery claim, or a familiar package image is only a lead. This is an investigational program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For Malaysia, the exact product, presentation, seller identity, current record status, and claimed supply route must resolve through the official sources on this page.
7 study records currently list 50 locations in this country, including 0 locations individually marked Recruiting.
Registry update: 24 July 2026Cagrilintide is an investigational clinical program. No seller listing in Malaysia can inherit the sponsor’s clinical identity, trial evidence, or regulatory status. Check any exact product and supplier claim in the destination records below.
Primary identity source: REDEFINE 1 Phase 3 study - NCT05567796 / ClinicalTrials.gov ↗A credible result must keep these separate. The official links answer different questions and should be checked in sequence.
REDEFINE 1 Phase 3 study - NCT05567796 is maintained by ClinicalTrials.gov. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open REDEFINE 1 Phase 3 study - NCT05567796 ↗QUEST3+ Product Search is maintained by National Pharmaceutical Regulatory Agency. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open QUEST3+ Product Search ↗Product registration FAQ is maintained by National Pharmaceutical Regulatory Agency. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open Product registration FAQ ↗Malaysia's NPRA distinguishes registered products from manufacturer, importer, and wholesaler licences. A MAL-looking number, hologram image, marketplace badge, research statement, or laboratory document should be matched to the current official product record and responsible entity.
The country guide supplies the local verification sequence. It does not convert an online listing into an authorized product or verified seller.
Use the NPRA product search with the MAL number, product name, holder, manufacturer, importer, or active ingredient, and confirm that the returned status is active at the time of the search.
Compare the registration number, product category, holder, manufacturer, dosage form, and pack to the offer. A copied MAL number or similar product name is not a complete match.
Confirm the relevant manufacturer, import, or wholesale authority independently because NPRA treats product registration and the licences for supply activities as different controls.
Open the live record and confirm its current status. A linked source begins the verification process; it does not mean Peptide Local authenticated a product or seller.